Wells Fargo & Company Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by research analysts at Wells Fargo & Company from $549.00 to $630.00 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 15.49% from the company’s current price.

A number of other research analysts also recently issued reports on the company. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Royal Bank of Canada raised their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Piper Sandler reiterated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $545.83.

Intuitive Surgical Trading Up 1.4 %

Shares of NASDAQ:ISRG traded up $7.40 during trading on Wednesday, reaching $545.49. 93,329 shares of the company traded hands, compared to its average volume of 1,438,130. Intuitive Surgical has a 52-week low of $314.38 and a 52-week high of $556.23. The firm has a market capitalization of $194.29 billion, a price-to-earnings ratio of 87.70, a P/E/G ratio of 5.41 and a beta of 1.38. The business’s fifty day moving average is $517.16 and its 200-day moving average is $475.65.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. On average, sell-side analysts predict that Intuitive Surgical will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,485 shares of company stock worth $26,128,102. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of the stock. Hazlett Burt & Watson Inc. raised its stake in shares of Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. raised its position in shares of Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the period. Ullmann Wealth Partners Group LLC lifted its stake in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares in the last quarter. Meeder Advisory Services Inc. raised its holdings in Intuitive Surgical by 0.3% during the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after acquiring an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC lifted its position in shares of Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after acquiring an additional 23 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.